DK1267924T3 - Immunterapeutiske metoder og sammensætninger - Google Patents

Immunterapeutiske metoder og sammensætninger

Info

Publication number
DK1267924T3
DK1267924T3 DK01929778.7T DK01929778T DK1267924T3 DK 1267924 T3 DK1267924 T3 DK 1267924T3 DK 01929778 T DK01929778 T DK 01929778T DK 1267924 T3 DK1267924 T3 DK 1267924T3
Authority
DK
Denmark
Prior art keywords
antigen presenting
presenting cells
compositions
relates
immunotherapeutic methods
Prior art date
Application number
DK01929778.7T
Other languages
English (en)
Inventor
James Dobbie
Original Assignee
Lamellar Biomedical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lamellar Biomedical Ltd filed Critical Lamellar Biomedical Ltd
Application granted granted Critical
Publication of DK1267924T3 publication Critical patent/DK1267924T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK01929778.7T 2000-03-24 2001-03-26 Immunterapeutiske metoder og sammensætninger DK1267924T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0007150.6A GB0007150D0 (en) 2000-03-24 2000-03-24 Immunotherapeutic methods and compositions
PCT/GB2001/001936 WO2001072277A2 (en) 2000-03-24 2001-03-26 Immunotherapeutic methods and compositions

Publications (1)

Publication Number Publication Date
DK1267924T3 true DK1267924T3 (da) 2012-05-29

Family

ID=9888324

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01929778.7T DK1267924T3 (da) 2000-03-24 2001-03-26 Immunterapeutiske metoder og sammensætninger

Country Status (13)

Country Link
US (2) US20040110695A1 (da)
EP (1) EP1267924B1 (da)
JP (1) JP2004517031A (da)
AT (1) ATE544470T1 (da)
AU (2) AU5646101A (da)
CA (1) CA2404325C (da)
DK (1) DK1267924T3 (da)
ES (1) ES2382070T3 (da)
GB (1) GB0007150D0 (da)
NO (1) NO333157B1 (da)
NZ (1) NZ522058A (da)
PT (1) PT1267924E (da)
WO (1) WO2001072277A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
PT1592441E (pt) * 2003-02-06 2012-05-21 Aduro Biotech Listeria atenuada relativamente à entrada em células não patogénicas, vacinas compreendendo a listeria e métodos para sua utilização
US11324698B2 (en) * 2003-08-28 2022-05-10 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
AU2004275550B2 (en) * 2003-09-25 2011-08-18 Lamellar Biomedical Limited Compositions and methods of using lamellar bodies for therapeutic purposes
EP1765289B1 (en) * 2004-07-07 2008-09-03 Statens Serum Institut Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
WO2007130465A2 (en) 2006-05-02 2007-11-15 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
CN102596177B (zh) * 2009-07-01 2014-05-28 阿昂梅迪克斯公司 来源于有核哺乳动物细胞的微囊泡及其应用
AU2011271830B2 (en) 2010-07-01 2014-08-14 Aeon Medix Inc Microvesicles derived from cell protoplast, and use thereof
EP2714017B1 (en) * 2011-06-02 2018-08-01 The Regents of The University of California Membrane encapsulated nanoparticles and method of use
WO2015021390A2 (en) 2013-08-08 2015-02-12 The Regents Of The University Of California Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
WO2015084677A1 (en) 2013-12-02 2015-06-11 Arytha Biosciences, Llc Toxoid preparation and uses thereof
US10098839B2 (en) 2014-03-20 2018-10-16 The Regents Of The University Of California Hydrogel toxin-absorbing or binding nanoparticles
WO2015187502A1 (en) 2014-06-02 2015-12-10 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders
US10434070B2 (en) 2015-01-02 2019-10-08 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to enable blood transfusion
US10610493B2 (en) 2015-04-29 2020-04-07 The Regents Of The University Of California Detoxification using nanoparticles
EP3632410A1 (en) 2018-10-05 2020-04-08 Lamellar Biomedical Limited Lipidic polynucleotide carriers for cellular delivery
EP3692984A1 (en) 2019-02-08 2020-08-12 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Annexin-coated particles

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
FR2645878B1 (fr) * 1989-04-17 1994-02-25 Institut Nal Sante Recherc Medic Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
AU665764B2 (en) * 1991-05-29 1996-01-18 Baxter International Inc. Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal disease and related conditions
JPH05339169A (ja) * 1992-03-03 1993-12-21 Dai Ichi Seiyaku Co Ltd 経口ワクチン
WO1997003703A1 (en) * 1995-07-21 1997-02-06 Rhone-Poulenc Rorer Pharmaceuticals Inc. Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
US5543152A (en) * 1994-06-20 1996-08-06 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5462752A (en) * 1994-07-28 1995-10-31 Prp, Inc. Inhibition of platelet binding
US5643599A (en) * 1995-06-07 1997-07-01 President And Fellows Of Harvard College Intracellular delivery of macromolecules
EP1634949B1 (en) * 1997-05-08 2010-12-15 Oncothyreon Inc. Method for generating activated T-cells and antigen-pulsed antigen-presenting cells
GB9807298D0 (en) * 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament
EP0976403A1 (en) * 1998-07-30 2000-02-02 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Adjuvant comprising pulmonary surfactant
US6290987B1 (en) * 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US6193997B1 (en) * 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules

Also Published As

Publication number Publication date
GB0007150D0 (en) 2000-05-17
US20040110695A1 (en) 2004-06-10
ES2382070T3 (es) 2012-06-05
EP1267924A2 (en) 2003-01-02
CA2404325A1 (en) 2001-10-04
PT1267924E (pt) 2012-05-24
NZ522058A (en) 2005-05-27
CA2404325C (en) 2012-06-12
NO333157B1 (no) 2013-03-18
WO2001072277A3 (en) 2002-06-13
AU5646101A (en) 2001-10-08
ATE544470T1 (de) 2012-02-15
NO20024571L (no) 2002-10-14
EP1267924B1 (en) 2012-02-08
NO20024571D0 (no) 2002-09-24
JP2004517031A (ja) 2004-06-10
US20080069866A1 (en) 2008-03-20
WO2001072277A2 (en) 2001-10-04
AU2001256461B2 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
DK1267924T3 (da) Immunterapeutiske metoder og sammensætninger
SI2351579T1 (sl) Polipeptidna cepiva za široko zaščito proti hipervirulentnim meningokoknim linijam
NZ331651A (en) BSW17 peptide immunogens for vaccination against and treatment of allergy
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
WO2005037190A3 (en) Multiplex vaccines
EP0804158A4 (en) PREPARATIONS AND METHOD FOR TRIGGERING CTL IMMUNITY
TR200002930T2 (tr) Kolaylaştırıcı kompozisyonlar
HK1039749A1 (en) Use of expressions of ctl and t-helper lymph cellsin vaccination
DK1104306T3 (da) Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf
IL150602A0 (en) Proteosome influenza vaccine
DK0555276T3 (da) Immunogene komplekser, især iscomer
ES2177927T3 (es) Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico.
DK0880360T3 (da) Hidtil ukendte fremgangsmåder til vaccination og vacciner dertil, hvilke vacciner omfatter en nucleinsyre, der koder en første epitop, og et peptid, der indeholder en sekundær epitop
DE60137347D1 (de) Neuer immunogener komplex
CA2232344A1 (en) Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
AU2002309259A1 (en) Improved polysaccharide and glycoconjugate vaccines_____________
WO2004030616A3 (en) Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
AU6078399A (en) Ligand presenting assembly (lpa), method of preparation and uses thereof
WO1996012190A3 (en) Presentation of hydrophobic antigens to t-cells by cd1 molecules
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
WO1999047102A3 (en) Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
WO2002036160A3 (es) Método de obtención de estructuras antigénicas que potencian la reactividad cruzada específica
MX9708226A (es) Vacunas que contienen una saponina y un esterol.